Our ddPCR method of surveying acute leukemia burden by blood TAA/ABL1 may be valuable for other tumors that also express these TAAs, such as chronic leukemias, lymphomas, breast, lung, pancreas and colon cancer. Here, ABL1 is linked to chronic leukemia.